Effectiveness of a Guided Mobile App Intervention for Depression and Anxiety in University Students (PROMES-U Study)
PROMES-U
2 other identifiers
interventional
600
1 country
1
Brief Summary
Background: Symptoms of depression and anxiety are prevalent among Spanish university students. Minimally guided online interventions have shown promise in reducing symptomatology and preventing increased mental distress. There is a need to evaluate the effectiveness of guided preventive mental health interventions for depression and anxiety in university students. Methods: two-arm multicenter randomized controlled trial (RCT), addressed to undergraduate students from 6 public universities with symptoms of depression and/or anxiety. Students will be evaluated through an online survey assessing mental health problems, use of mental health services, sociodemographic variables, self-perceived health, childhood and adolescent adversities, recent stressful events, social networks, personality and university experiences. A total of 600 students will be randomly assigned to: intervention group (guided E-health prevention intervention) or control group (treatment as usual with self-monitoring). The intervention, in app format, is based on principles of cognitive behavioral therapy, includes weekly feedback based on content and participation from a psychologist and self-monitoring. Assessments will take place post-intervention (up to 6 weeks), at 6 months and 12 months after randomization. The primary outcome will be the reduction of depressive or anxiety symptoms post-intervention, assessed with the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder-7 (GAD-7) and the Patient Health Questionnaire-Anxiety and Depression Scale (PHQ-ADS). Secondary outcomes of the RCT will be mental wellbeing, academic stress, comorbid symptoms, and adherence. Analyses will be conducted on an intention-to-treat and per protocol basis. Discussion: The results of the PROMES-U RCT will provide valuable information on a guided preventive online intervention that could be delivered in the campus context. In addition, results will provide information on the positive impact of the intervention on other relevant factors involved in mental health among university students.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2023
CompletedFirst Posted
Study publicly available on registry
October 11, 2023
CompletedStudy Start
First participant enrolled
October 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedOctober 31, 2024
October 1, 2024
1 year
September 28, 2023
October 29, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Change of depressive symptoms
The primary outcome will be the change of depressive symptoms at post-intervention (up to 6 weeks), 6 months and 12 months post randomization, considering the minimal clinically relevant change in the scores of Patient Health Questionnaire-9 (PHQ-9) and the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS). The PHQ-9 range from 0 to 27, higher scores mean a worse outcome. The PHQ-ADS range from 0 to 48 with higher scores indicating more severe depression.
Up to 6 weeks, at 6 months and 12 months after randomization
Change of anxiety symptoms
The primary outcome will be the change of anxiety symptoms at post-intervention (up to 6 weeks), 6 months and 12 months post randomization, considering the minimal clinically relevant change in the scores of Generalized Anxiety Disorder -7 (GAD-7) he Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS). The GAD-7 range from 0 to 21, higher scores mean a worse outcome. The PHQ-ADS range from 0 to 48 with higher scores indicating more severe anxiety.
Up to 6 weeks and at 6 months and 12 months post randomization
Study Arms (2)
MyMoodCoach Intervention
EXPERIMENTALTreatment-as-usual monitoring control group
NO INTERVENTIONInterventions
The MyMoodCoach prevention intervention is an evidence-based online intervention based on cognitive-behavioral therapy principles such as behavioral activation, problem solving and challenging negative thoughts.
Eligibility Criteria
You may qualify if:
- Eligible participants are all undergraduate students at the 6 participating universities and students followed in the PROMES-U observational study
- Having 18 years of age or more
- Having literacy in Spanish
- Having access to a smartphone (Android or Apple)
- With mild or moderate depression and/or anxiety symptoms screened (i.e., depression (5≤ (PHQ-9) ≤14); and/or anxiety (5≤ GAD-7 ≤14).
You may not qualify if:
- Moderately severe or severe depression and/or anxiety (i.e., PHQ-9≥15 and/or GAD-7≥15)
- High suicide risk
- A history of severe psychiatric disorder (e.g., bipolar, psychosis)
- Being on mental health treatment (i.e., medication, psychotherapy or other intervention)
- Students with high suicide risk will receive a clinical alert recommending them to visit a specialist and a list of available mental health resources.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of the Balearic Islandslead
- Hospital del Mar Research Institute (IMIM)collaborator
- Universitat Jaume Icollaborator
- Universidad Miguel Hernandez de Elchecollaborator
- Universitat Pompeu Fabracollaborator
- Universidad de Zaragozacollaborator
- University of Malagacollaborator
- Instituto de Salud Carlos IIIcollaborator
Study Sites (1)
Miquel Roca
Palma de Mallorca, Balearic Islands, 07122, Spain
Related Publications (1)
Ballester L, Gili M, Roca M, Forteza-Rey I, Soto-Sanz V, Vilagut G, Amigo F, Moreno-Kustner B, Mortier P, Piqueras JA, Portillo-Van Diest A, Rebagliato M, Rodriguez-Jimenez T, Alonso J; PROMES-U study group. Effectiveness of a guided mobile app intervention for depression and anxiety in university students (PROMES-U study): protocol of a multicenter randomized controlled trial. BMC Public Health. 2025 Nov 3;25(1):3740. doi: 10.1186/s12889-025-24752-3.
PMID: 41184908DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jordi Alonso
Hospital de Mar Medical Research Institute (IMIM)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 28, 2023
First Posted
October 11, 2023
Study Start
October 25, 2024
Primary Completion
November 1, 2025
Study Completion
November 1, 2025
Last Updated
October 31, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share